[
  {
    "ts": null,
    "headline": "This 12 Dividend Stock Portfolio Will Pay Your Bills – Every Week",
    "summary": "Most dividend stocks pay quarterly—but your bills don’t. Rent, groceries, gas, surprise car repairs… life doesn’t come once every three months. That’s why some investors are building what’s called a Weekly Paycheck Portfolio—a curated list of dividend-paying stocks staggered to deliver consistent income every week of the year. With the right mix of stocks across […]",
    "url": "https://finnhub.io/api/news?id=db54078f4040b6a9e482ab7dff995d522883338088e53fcd73ef0db932611d21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753117446,
      "headline": "This 12 Dividend Stock Portfolio Will Pay Your Bills – Every Week",
      "id": 136031297,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Most dividend stocks pay quarterly—but your bills don’t. Rent, groceries, gas, surprise car repairs… life doesn’t come once every three months. That’s why some investors are building what’s called a Weekly Paycheck Portfolio—a curated list of dividend-paying stocks staggered to deliver consistent income every week of the year. With the right mix of stocks across […]",
      "url": "https://finnhub.io/api/news?id=db54078f4040b6a9e482ab7dff995d522883338088e53fcd73ef0db932611d21"
    }
  },
  {
    "ts": null,
    "headline": "Looking for Cheap Stocks? Healthcare Shares Haven’t Looked This Good in 30 Years.",
    "summary": "A Goldman ranking of S&P 500 sectors by price/earnings ratios reveals opportunities in healthcare stocks.",
    "url": "https://finnhub.io/api/news?id=cd17fd1452b4268272a9f25932e02fa3a251bf4ddd1b877b3cdb8c32293636a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753116000,
      "headline": "Looking for Cheap Stocks? Healthcare Shares Haven’t Looked This Good in 30 Years.",
      "id": 136031230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "A Goldman ranking of S&P 500 sectors by price/earnings ratios reveals opportunities in healthcare stocks.",
      "url": "https://finnhub.io/api/news?id=cd17fd1452b4268272a9f25932e02fa3a251bf4ddd1b877b3cdb8c32293636a7"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock underperforms Monday when compared to competitors",
    "summary": "AbbVie Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=6e3bfa02e2835e16ae8ba7ea539c7938c94f490b726ef92062d0b61908aae3c6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753115460,
      "headline": "AbbVie Inc. stock underperforms Monday when compared to competitors",
      "id": 136041737,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=6e3bfa02e2835e16ae8ba7ea539c7938c94f490b726ef92062d0b61908aae3c6"
    }
  },
  {
    "ts": null,
    "headline": "Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025",
    "summary": "J&J, Novartis and Allogene Therapeutics are making bold oncology moves as demand surges for next-generation cancer therapies.",
    "url": "https://finnhub.io/api/news?id=b68b0e8b783d65219841418cceddcf5f3bd8e35ed1c4cc6bf5878cb8d8027ef6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753105260,
      "headline": "Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025",
      "id": 136025389,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "J&J, Novartis and Allogene Therapeutics are making bold oncology moves as demand surges for next-generation cancer therapies.",
      "url": "https://finnhub.io/api/news?id=b68b0e8b783d65219841418cceddcf5f3bd8e35ed1c4cc6bf5878cb8d8027ef6"
    }
  }
]